FWFelicia Widyaputri

Felicia Widyaputri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Felicia Widyaputri has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Muhammad Bayu Sasongko

    Department of Ophthalmology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

    7 shared publications
  • Jennifer J. Conn

    Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

    3 shared publications
  • Lyndell Lp Lim

    Centre for Eye Research Australia Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia

    3 shared publications
  • Alexis Shub

    Perinatal Department, Mercy Hospital for Women, Heidelberg, Victoria, Australia

    2 shared publications
  • Alison J. Nankervis

    Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

    2 shared publications
  • Anggraeni Puspita

    Affiliation Department of Ophthalmology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada – Dr. Sardjito General Hospital, Yogyakarta, Indonesia

    2 shared publications

Latest Publications

  • Open Access

    Adherence to the recommended diabetic retinopathy screening guidelines in pregnant women with pregestational diabetes: a cross-sectional survey study

    by Felicia Widyaputri, Sophie L. Rogers, Alison J. Nankervis, Jennifer J. Conn, Alexis Shub, Sandra E. Staffieri, Muhammad B. Sasongko, Xavier J. Fagan, Robert C. A. Symons, Lyndell L. Lim

    Objective Diabetic retinopathy (DR) in pregnancy can cause blindness. National guidelines recommend at least one eye examination in early pregnancy, then ideally 3-monthly, through to the postpartum for pregnant women with pregestational diabetes. Here we examined adherence rates, barriers and enablers to recommended DR screening guidelines. Design Cross-sectional survey study, as part of a larger prospective cohort study. Setting Participants were recruited from two tertiary maternity hospitals in Melbourne, Australia. Participants Of the 173 pregnant women with type 1 (T1D) or type 2 diabetes (T2D) in the main cohort study, with an additional four who participated solely in this survey study, 130 (74.3%) completed the survey. Primary and secondary outcome measures This study calculated rates of adherence to guideline-recommended DR screening schedules and collected data on the enablers and barriers to attendance using a modified Compliance with Annual Diabetic Eye Exams Survey. Each of the 5-point Likert-scale survey items was compared between adherent and non-adherent participants using the Wilcoxon rank-sum test and logistic regression models were constructed to quantify associations as ORs. Results A retinal assessment was undertaken at least once during pregnancy in 86.3% of participants, but only 40.9% attended during their first trimester and only 21.2% attended the recommended number of examinations. Competing priorities were the main barriers to adherence, with eye examinations ranked as the fourth priority (IQR 4th–5th) among other health appointments during pregnancy. Meanwhile, knowledge of the benefits of eye screening examinations, eye-check reminders and support from relatives was identified as enablers. Conclusions Despite the risk of worsening DR during pregnancy, less than half of the participants adhered to recommended screening guidelines, suggesting that eye health is not a priority. Proactive measures to integrate care are needed to prevent visual loss in this growing population.


  • Open Access

    Incidence and progression of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes

    by Muhammad Bayu Sasongko, Gandhi Anandika Febryanto, Supanji Haryanto, Firman Setya Wardhana, Yeni Dwi Lestari, Anggraeni Puspita, Felicia Widyaputri

    Objectives: To report the incidence and progression rate of diabetic retinopathy (DR) and blindness in Indonesian adults with type 2 diabetes. Methods: This was a prospective cohort study of 899 adults aged >30 years with confirmed type 2 diabetes. All participants underwent standardized clinical and eye examinations. Two-field retinal photographs were taken. DR was graded by trained grader masked to participants’ clinical details. We categorized DR as follows: mild, moderate, severe non-proliferative (NPDR), and proliferative DR (PDR). Additional category of vision-threatening DR (VTDR) included severe NPDR or more, or moderate NPDR with clinically significant macular edema. Blindness was defined as visual acuity ≤3/60. At least 1-step progression was categorized as DR progressing. Cox-proportional hazard model was used. Results: The incidence and progression of DR were 34.6 and 35.1, and incidence of VTDR and blindness were 24.5 and 8.33/1000 person-years, respectively. Longer diabetes duration was associated with increasing the risk of developing DR (Hazard ratio 1.37 [95% confidence interval 1.10–1.72]) and VTDR (2.00 [1.60–2.50]) and progressing DR (1.50 [1.23–1.84]) in 5 years. Obesity was associated with increased risk of developing DR (1.75 [1.14–2.68]) and the presence of gangrene (2.54 [1.49–4.35]) and neuropathy (1.50 [1.07–2.10]) at baseline increased the risk of progressing DR in 5 years. Living in rural area was associated with increased risk of blindness (2.50 [1.03–5.88]). Conclusions: We reported the incidence and progression rate of DR, VTDR, and blindness, and documented that longer diabetes duration increased the risk of DR and VTDR in 5 years.


  • Open Access

    Incidence and progression of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes

    by Muhammad B Sasongko, Gandhi A Febryanto, Supanji, Firman S Wardhana, Yeni D Lestari, Anggraeni Puspita, Felicia Widyaputri

    Objectives: To report the incidence and progression rate of diabetic retinopathy (DR) and blindness in Indonesian adults with type 2 diabetes. Methods: This was a prospective cohort study of 899 adults aged >30 years with confirmed type 2 diabetes. All participants underwent standardized clinical and eye examinations. Two-field retinal photographs were taken. DR was graded by trained grader masked to participants’ clinical details. We categorized DR as follows: mild, moderate, severe non-proliferative (NPDR), and proliferative DR (PDR). Additional category of vision-threatening DR (VTDR) included severe NPDR or more, or moderate NPDR with clinically significant macular edema. Blindness was defined as visual acuity ≤3/60. At least 1-step progression was categorized as DR progressing. Cox-proportional hazard model was used. Results: The incidence and progression of DR were 34.6 and 35.1, and incidence of VTDR and blindness were 24.5 and 8.33/1000 person-years, respectively. Longer diabetes duration was associated with increasing the risk of developing DR (Hazard ratio 1.37 [95% confidence interval 1.10-1.72]) and VTDR (2.00 [1.60-2.50]) and progressing DR (1.50 [1.23-1.84]) in 5 years. Obesity was associated with increased risk of developing DR (1.75 [1.14-2.68]) and the presence of gangrene (2.54 [1.49-4.35]) and neuropathy (1.50 [1.07-2.10]) at baseline increased the risk of progressing DR in 5 years. Living in rural area was associated with increased risk of blindness (2.50 [1.03-5.88]). Conclusions: We reported the incidence and progression rate of DR, VTDR, and blindness, and documented that longer diabetes duration increased the risk of DR and VTDR in 5 years.

  • Open Access

    Progression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum

    by Felicia Widyaputri, Edmund W. C. Khong, Sophie L. Rogers, Alison J. Nankervis, Jennifer J. Conn, Muhammad B. Sasongko, Alexis Shub, Xavier J. Fagan, Daryl Guest, Robert C. A. Symons, et al.

    Background: Diabetic retinopathy (DR) may worsen during pregnancy, but its course in the postpartum remains poorly understood. Understanding the natural history of DR during and after pregnancy can help determine when sight‐threatening DR treatment should be administered.Methods: A prospective longitudinal cohort study recruited pregnant women with pre‐existing type 1 (T1D) or type 2 diabetes from two tertiary Diabetes Antenatal Clinics in Melbourne, Australia. Eye examination results in early pregnancy, late pregnancy, and up to 12‐months postpartum were compared to determine DR changes. Two‐field fundus photographs and optical coherence tomography scans were used to assess DR severity.Results: Overall, 105 (61.4%) women had at least two eye examinations during the observation period. Mean age was 33.5 years (range 19–51); 54 women (51.4%) had T1D; 63% had HbA1c <7% in early pregnancy. DR progression rate was 23.8% (95% CI 16.4–32.6). Having T1D (RR 4.96, 95% CI 1.83–13.46), pre‐existing DR in either eye (RR 4.54, 95% CI 2.39–8.61), and elevated systolic blood pressure (adjusted RR 2.49, 95% CI 1.10–5.66) were associated with increased risk of progression. Sight‐threatening progression was observed in 9.5% of women. Among the 19 eyes with progression during pregnancy, 15 eyes remained stable, three eyes progressed, and only one eye regressed in the postpartum.Conclusions: Nearly 1 in 4 women had DR progression from conception through to 12‐months postpartum; almost half of these developing sight‐threatening disease. DR progression occurring during pregnancy was found to predominantly remain unchanged, or worsen, after delivery, with very few eyes spontaneously improving postpartum.


  • Open Access

    Accuracy of Low-Cost, Smartphone-Based Retinal Photography for Diabetic Retinopathy Screening: A Systematic Review

    by Mohammad Eko Prayogo, Alfia Fatma Zaharo, Novandriati Nur Rizky Damayanti, Felicia Widyaputri, Jarir At Thobari, Vina Yanti Susanti, Muhammad Bayu Sasongko

    Purpose: Diabetic retinopathy (DR) is a leading cause of blindness. Early DR screening is essential, but the infrastructure can be less affordable in low resource countries. This study aims to review the accuracy of low-cost smartphone-based fundus cameras for DR screening in adult patients with diabetes. Methods: We performed a systematic literature search to find studies that reported the sensitivity and specificity of low-cost smartphone-based devices for fundus photography in adult patients with diabetes. We searched three databases (MEDLINE, Google Scholar, Scopus) and one register (Cochrane CENTRAL). We presented the accuracy values by grouping the diagnosis into three: any DR, referrable DR, and diabetic macular oedema (DMO). Risk of bias and applicability of the studies were assessed using QUADAS-2. Results: Five out of 294 retrieved records were included with a total of six smartphone-based devices reviewed. All of the reference diagnostic methods used in the included studies were either indirect ophthalmoscopy or slit-lamp examinations and all smartphone-based devices’ imaging protocols used mydriatic drops. The reported sensitivity and specificity for any DR were 52– 92.2% and 73.3– 99%; for referral DR were 21– 91.4% and 64.9– 100%; and for DMO were 29.4– 81% and 95– 100%, respectively. Conclusion: Sensitivity available low-cost smartphone-based devices for DR screening were acceptable and their specificity particularly for detecting referrable DR and DMO were considerably good. These findings support their potential utilization for DR screening in a low resources setting.


  • Open Access

    Prevalence of diabetes in pregnancy and microvascular complications in native Indonesian women: The Jogjakarta diabetic retinopathy initiatives in pregnancy (Jog-DRIP)

    by Felicia Widyaputri, Lyndell L. Lim, Tiara Putri Utami, Annisa Pelita Harti, Angela Nurini Agni, Detty Siti Nurdiati, Tri Wahyu Widayanti, Supanji, Firman Setya Wardhana, Mohammad Eko Prayogo, et al.

    Objectives: To report the prevalence of total diabetes in pregnancy (TDP) and diabetes-related microvascular complications among Indonesian pregnant women. Methods: We conducted a community-based cross-sectional study with multi-stage, cluster random sampling to select the participating community health centers (CHC) in Jogjakarta, Indonesia between July 2018-November 2019. All pregnant women in any trimester of pregnancy within the designated CHC catchment area were recruited. Capillary fasting blood glucose (FBG) and blood glucose (BG) at 1-hour (1-h), and 2-hour (2-h) post oral glucose tolerance test (OGTT) were measured. TDP was defined as the presence of pre-existing diabetes or diabetes in pregnancy (FBG ≥7.0 mmol/L, or 2-h OGTT ≥11.1 mmol/L, or random BG ≥11.1 mmol/L with diabetes symptoms). Disc and macula-centered retinal photographs were captured to assess diabetic retinopathy (DR). Blood pressure, HbA1c and serum creatinine levels were also measured. Results: A total of 631/664 (95%) eligible pregnant women were included. The median age was 29 (IQR 26–34) years. The prevalence of TDP was 1.1% (95%CI 0.5, 2.3). It was more common in women with chronic hypertension (p = 0.028) and a family history of diabetes (p = 0.015). Among the TDP group, 71% had a high HbA1c, but no DR nor nephropathy were observed. Conclusions: Although a very low prevalence of TDP and no diabetes-related microvascular complications were documented in this population, there is still a need for a screening program for diabetes in pregnancy. Once diabetes has been identified, appropriate management can then be provided to prevent adverse outcomes.


  • Open Access

    Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum

    by Felicia Widyaputri, Sophie L. Rogers, Edmund W. C. Khong, Alison J. Nankervis, Jennifer J. Conn, Muhammad B. Sasongko, Alexis Shub, Xavier J. Fagan, Daryl Guest, Robert C. A. Symons, et al.

    Background: Diabetic retinopathy (DR) may be affected by pregnancy. The majority of prevalence data regarding DR in pregnancy predate the advent of contemporary guidelines for diabetes management during pregnancy. This study reports DR prevalence and associated risk factors in women with pregestational diabetes during pregnancy and the postpartum in Australia.Methods: A total of 172 pregnant women with type 1 (T1DM) or type 2 diabetes diagnosed pre‐pregnancy were prospectively recruited from two obstetrics hospitals in Melbourne (November 2017–March 2020). Eye examinations were scheduled in each trimester, at 3‐, 6‐, and 12‐months postpartum. DR severity was graded from two‐field fundus photographs by an independent grader utilising the Airlie House Classification. Sight‐threatening DR (STDR) was defined as the presence of diabetic macular oedema or proliferative DR.Results: Overall, 146 (84.9%) women had at least one eye examination during pregnancy. The mean age was 33.8 years (range 19–51), median diabetes duration was 7.0 years (IQR 3.0–17.0), 71 women (48.6%) had T1DM. DR and STDR prevalence during pregnancy per 100 eyes was 24.3 (95% CI 19.7–29.6) and 9.0 (95% CI 6.1–12.9); while prevalence in the postpartum was 22.2 (95% CI 16.5–29.3) and 10.0 (95% CI 5.4–17.9), respectively. T1DM, longer diabetes duration, higher HbA1c in early pregnancy, and pre‐existing nephropathy were significant risk factors.Conclusions: The prevalence of DR in pregnant women was similar to the non‐pregnant diabetic population in Australia. One in nine participants had STDR during pregnancy and the postpartum, highlighting the need to optimise DR management guidelines in pregnancy given the significant risk of vision loss.